Financials

  • Market Capitalization 1.57 B
  • Employee 140
  • Founded 2011
  • CEO N/A
  • Website www.absci.com
  • Headquarter Washington, United States
  • FIGI BBG011N54CJ8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.15
Rapporto prezzo/fatturato
170.48

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2146
BCAX
Bicara Therapeutics Inc. - Common Stock
24.83 USD+0.40%+0.40%-7.63%+71.95%1.64 B USD
2150
FBRX
Forte Biosciences, Inc. - Common Stock
76.99 USD0.00%+0.08%+0.50%+162.32%1.63 B USD
2173
XERS
Xeris Biopharma Holdings, Inc. - Common Stock
8.48 USD-1.40%-2.53%+3.04%+7.21%1.55 B USD
2175
TYRA
Tyra Biosciences, Inc. - Common Stock
25.70 USD-1.65%-3.24%-17.94%+79.22%1.53 B USD

Notizie